Given that ENO1 is highly expressed on the plasma membrane of tumor cells, is detectable in circulation, and is functionally independent of upstream genetic alterations, it represents a promising and broadly applicable target for cancer therapy. This evidence concerns the gene ENO1 and neoplasm.